Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 451.5 SEK 1.23% Market Closed
Market Cap: 14.2B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

Xvivo Perfusion AB
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xvivo Perfusion AB
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
Xvivo Perfusion AB
STO:XVIVO
Effect of Foreign Exchange Rates
-kr14.4m
CAGR 3-Years
-106%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Effect of Foreign Exchange Rates
-kr76k
CAGR 3-Years
48%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
D
Doxa AB
STO:DOXA
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bactiguard Holding AB
STO:BACTI B
Effect of Foreign Exchange Rates
-kr1.7m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Effect of Foreign Exchange Rates
-€298k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Xvivo Perfusion AB
Glance View

Market Cap
14.2B SEK
Industry
Health Care

Xvivo Perfusion AB is a medical technology company. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 92 full-time employees. The company went IPO on 2012-10-08. The firm operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO Perfusion System (XPS) machines. The Non-Durable goods segment implies revenue from the sale of products and services that are solutions and disposable items. The Company’s product portfolio consists of Perfadex, STEEN Solution, XPS, XPS Disposable Kit, XVIVO Lung Cannula Set, XVIVO Organ Chamber, XPS PGM Disposable Sensors and Silicone Tubing Set. The firm markets its products in Europe, Asia, Middle East, and North & South America.

XVIVO Intrinsic Value
251.13 SEK
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Xvivo Perfusion AB's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
-14.4m SEK

Based on the financial report for Sep 30, 2024, Xvivo Perfusion AB's Effect of Foreign Exchange Rates amounts to -14.4m SEK.

What is Xvivo Perfusion AB's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 3Y
-106%

Over the last year, the Effect of Foreign Exchange Rates growth was -296%. The average annual Effect of Foreign Exchange Rates growth rates for Xvivo Perfusion AB have been -106% over the past three years .

Back to Top